Hosted on MSN11mon
Amylyx’s ALS Drug Fails Trial, Raising Questions About Company’s Future
The Amylyx drug, called Relyvrio, had provided some hope in what is otherwise an extremely grim diagnosis. There are only three other approved treatments for the disease, none of them curative.
pharmaphorum8d
Relief for Amylyx as FDA clears controversial ALS drug Relyvrio
Meanwhile, Relyvrio has already been conditionally approved in Canada under the Albrioza brand name, although it has not yet launched there, as Amylyx remains in pricing negotiations.
pharmaphorum6d
Amylyx wields axe as it pulls ALS drug from the market
Amylyx confirmed today that it will withdraw its amyotrophic lateral sclerosis (ALS) therapy Relyvrio/Albrioza from the market in the US and Canada, shortly after the drug failed a clinical trial.
Hosted on MSN11mon
Amylyx Stock Wipes Out Nearly All Of Its Value, Crashing 82%, After Pivotal ALS Drug Failure
Amylyx stock crashed Friday, losing almost all of its value, after the company said its approved ALS treatment, Relyvrio, failed in a pivotal study. Please watch the video at Investors.com - How ...
FierceBiotech18d
FDA gives Amylyx green light for phase 1 ALS trial after clinical hold
The trial marks a continuation of Amylyx's efforts in the disease following last year’s market withdrawal of Relyvrio (sodium phenylbutyrate and taurursodiol). The drug failed to beat placebo at ...
BioSpace17d
FDA Presses Pause on Atara’s Programs, Play on Amylyx’s ALS Assets
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a third-party provider while releasing Amylyx’s investigational ALS therapy from a ...
ETF Daily News26d
Amylyx Pharmaceuticals Enters Underwriting Agreement for Public Offering
Amylyx Pharmaceuticals expressed that any forward ... The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the ...
CNN1y
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals ... Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge ...
Seeking Alpha29d
Amylyx stock dips after pricing $60M stock offering
Amylyx Pharmaceuticals (NASDAQ:AMLX) has priced a public offering of ~17.14M shares of its common stock at $3.50 a share. In addition, Amylyx has granted the underwriter a 30-day option to ...